Search

everythinglearnresearchcommunity

for

Search:↓

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Larger prostate size, longer surgery, and smoking increase risks, while finasteride and experienced surgeons reduce them during prostate surgery.

A young dog with an enlarged prostate and cysts improved significantly after treatment and surgery.

Early balding may be a sign of future prostate problems.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Certain drugs that block specific enzymes can help treat prostate diseases.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

A new method was developed to make finasteride for treating hair loss.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Dutasteride reduces DHT more effectively than finasteride.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

A new compound that could treat various androgen-related conditions was created and analyzed.

Unripe Rubus occidentalis extracts may help treat benign prostatic hyperplasia.

A new compound was made that might help treat diseases related to male hormones.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.